Guides

Cosmetic regulatory guides.

Plain explainers on selling cosmetics across the EU, UK, Switzerland and the United States.

Cosmetic regulatory guides, section banner

Cross-border cosmetic regulation is complex, and good information is hard to find. These guides set out, market by market, what the law requires and what a brand has to do to comply. They are written as practical references for founders and teams planning to expand. If you would rather hand the whole thing over, that is what CIG does.

Each of the four markets below is a separate legal regime with its own rules, its own portal, and its own paperwork. A notification in one does nothing for the others. This hub explains the shared vocabulary first, then the requirements market by market, so you can see what applies to your products before you read the detailed guide for each region.

Reference library

The guide library, organised by market.

European Union

The EU machinery in depth: the notification, the Responsible Person, and the documents behind them.

European Union

The CPNP notification, explained

Who files, what goes in, nanomaterials, confidentiality and cost.

Read the CPNP guide
European Union

EU Responsible Person requirements

Who needs one, who can hold the role, and what it does.

Read the RP guide
European Union

Switching your EU Responsible Person

The mandate, the PIF transfer, CPNP updates and the label, in order.

Read the switching guide
European Union

CPSR required inputs

The data your assessor needs, and which inputs set the timeline.

Read the inputs guide
European Union

CPSR cost and timeline

What it costs, what drives price, and why the lab sets the calendar.

Read the cost guide
European Union

The Product Information File, explained

Article 11 contents, the ten-year rule, and PIF vs CPSR.

Read the PIF guide
European Union

CPSR vs PIF vs notification

The safety report, the dossier and the filing: side by side, in order.

Read the comparison
European Union

Banned and restricted ingredients

Retinol, kojic acid, hydroquinone and more: the actual annex entries, captured.

Read the ingredient guide
European Union

Cosmetic claims rules

Natural, clean, hypoallergenic: the six criteria and the banned claims.

Read the claims guide
European Union

Cruelty-free and the law

Article 18’s bans, and what the bunny logos add on top.

Read the guide
European Union

Private label compliance

Your name on the jar means your file: what white-label brands actually owe.

Read the guide
European Union

Cosmetic testing requirements

Stability, challenge and micro: what each proves and how long it takes.

Read the testing guide
Testing

Microbiology testing

ISO methods, the pathogen panel, and the limits under ISO 17516.

Read the guide
Testing

Challenge testing (PET)

ISO 11930, the 28-day protocol, and Criteria A and B.

Read the guide
Testing

Stability testing

Accelerated studies, PAO support, and the launch-timeline long pole.

Read the guide

Start here

The words every guide uses.

Four terms come up on almost every page: Responsible Person, PIF, CPSR, and notification. Brands often treat them as one thing. They are separate steps, and each market handles them differently.

Responsible Person

The Responsible Person is the legal entity accountable for a cosmetic product on a given market. In the EU, Regulation (EC) No 1223/2009 requires every product to have a Responsible Person established in the Union. That person holds the Product Information File, verifies the safety report, files the notification, checks labelling and claims, and is the official contact for authorities, including during a recall. The role can be filled by the manufacturer, the importer, a distributor, or a third-party service provider. A non-EU brand cannot be its own EU Responsible Person, so it must appoint a third-party Responsible Person or set up its own EU entity. The Responsible Person's name and address must appear on the product label. The liability is continuous: it lasts for the whole time the product is on the market, not just at launch.

Product Information File (PIF)

The PIF is the dossier a Responsible Person keeps for each product and makes available to authorities on request. Under Article 11 of Regulation 1223/2009 it must contain: a description of the product, the Cosmetic Product Safety Report, a description of the manufacturing method with a statement of compliance with good manufacturing practice (ISO 22716), proof of the claimed effect where the nature of the claim justifies it, and data on any animal testing. The PIF must be kept for ten years after the last batch was placed on the market.

Cosmetic Product Safety Report (CPSR)

The CPSR is the signed safety assessment that sits inside the PIF. It follows Annex I of Regulation 1223/2009 and has two parts. Part A, the safety information, covers the quantitative and qualitative composition, physico-chemical characteristics and stability, microbiological quality including challenge testing, impurities and traces and packaging, normal and reasonably foreseeable use and exposure, the toxicological profile, and any undesirable effects. Part B, the safety assessment, states the conclusion, any warnings and instructions for use, the reasoning behind the assessment including the Margin of Safety, and the assessor's name, address, qualification, date, and signature. Part B can only be signed by a qualified assessor who holds a university diploma in pharmacy, toxicology, medicine, or a similar discipline recognised by an EU Member State. A safety report written for another market, such as a US report, does not transfer to the EU format, so it usually has to be redone.

Notification

Notification is the act of registering a product with the authorities before it goes on sale. Each market has its own system. The EU uses the CPNP (Cosmetic Product Notification Portal). Great Britain uses the SCPN (Submit Cosmetic Product Notification) service run by the Office for Product Safety and Standards (OPSS). The US uses FDA product listing under MoCRA. Switzerland has no pre-market notification portal at all. These systems are separate and do not share data, so notifying in one market does nothing for the others.

The four regimes

What each market requires.

The requirements below are the legal baseline for placing a cosmetic product on each market. The linked guides go deeper on process, documents, and timelines.

European Union

The EU regime runs on Regulation (EC) No 1223/2009. Every product needs a Responsible Person established in the Union, a Product Information File, a signed CPSR, and a CPNP notification. The CPNP notification is required under Article 13 before a product is placed on the EU market. Once a product is notified in CPNP, no further national-level notification is needed within the EU. Products containing nanomaterials require a separate notification under Article 16.

The CPNP portal itself is free of charge. The cost is in appointing a Responsible Person and preparing the documentation. A notification requires the product name, category and function, the Responsible Person's contact details, the full INCI formulation, images of the label and packaging, the CPSR reference and the toxicologist's details, and manufacturing country and batch information. CPNP data is made available only to competent authorities for market surveillance and to poison centres for medical treatment. Full product and formula data is not visible to competitors or the public.

Compliance is size-blind. There is no small-business exemption and no turnover threshold. A hobbyist selling a few bars of soap faces the same mandatory Responsible Person, PIF, and CPSR burden as a multinational.

United Kingdom

After Brexit, Great Britain runs its own regime, effective 1 January 2021: the retained version of Regulation 1223/2009, known as the UK Cosmetics Regulation, enforced through the Cosmetic Products Enforcement Regulations 2013. A product made available in Great Britain must have a Responsible Person established in the UK, and notification goes through the SCPN service operated by OPSS, which replaced CPNP for the Great Britain market.

A UK Responsible Person needs a genuine UK-established address. PO boxes and mail-forwarding addresses do not qualify. The UK Responsible Person keeps the PIF for ten years after the last batch, notifies OPSS before the product is made available, and reports serious undesirable effects. A brand selling into both the EU and Great Britain needs both a UK Responsible Person and a separately established EU Responsible Person. One Responsible Person cannot cover both, and CPNP and SCPN operate independently, each requiring its own notification.

Northern Ireland is treated separately from Great Britain. Under the Windsor Framework, the Northern Ireland market continues to follow EU Regulation 1223/2009, so it aligns with the EU Responsible Person and CPNP route rather than the Great Britain UK Responsible Person and SCPN route.

Switzerland

Switzerland sits under the Federal Act on Foodstuffs and Utility Articles (817.0) and its ordinance, with cosmetics governed by Ordinance 817.023.331. Article 54 requires cosmetics to comply with the annexes of EU Regulation 1223/2009 for prohibited ingredients, colourants, and preservatives, so the ingredient rules track the EU. The rest of the compliance chain is Swiss.

An EU Responsible Person does not cover Switzerland. The responsible person, whether the manufacturer, the importer, or an appointed agent, must have an address on Swiss territory, and the obligation cannot be delegated to anyone located abroad. If no Swiss responsible person is appointed, the company's CEO or equivalent legal representative becomes the responsible person by default. Switzerland has no pre-market notification portal and no access to CPNP. In-market control relies on cantonal laboratories across the 26 cantons carrying out post-market inspections, so a brand must hold a self-monitoring dossier that is ready to show on request. The PIF must be kept for ten years from the date the last batch was first placed on the market. An existing PIF compiled abroad can satisfy Swiss requirements if it complies with Swiss cosmetics and labelling rules, and it may be written in an official Swiss language or in English. Labelling warnings and instructions must appear in at least one official Swiss language: German, French, or Italian.

United States (MoCRA)

MoCRA, the Modernization of Cosmetics Regulation Act, is the federal US regime. The Responsible Person is the manufacturer, packer, or distributor whose name appears on the product label. That person must list each marketed cosmetic product with the FDA, including its ingredients, and update the listing annually. The manufacturing facility must also be registered. These are two separate obligations: the manufacturer registers the facility, and the brand named on the label does the product listing and the adverse-event reporting. Assuming a contract manufacturer handles all of it is a common and costly error.

There is no FDA fee to register a facility or list a product under section 607 of the FD&C Act. Registration and listing use FDA's free Cosmetics Direct tool, which authors submissions in the SPL (Structured Product Labeling) XML format; paper alternatives are Form FDA 5066 for registration and Form FDA 5067 for listing. An FDA Establishment Identifier (FEI) is required before submitting. Listing a product with the FDA does not mean it is FDA approved. The FDA does not approve cosmetic products before they go on the market.

MoCRA defines a small business as one whose average gross annual US cosmetic sales over the previous three-year period are under 1,000,000 US dollars. Qualifying small businesses are exempt from good manufacturing practice requirements, facility registration, and product listing. The exemption is narrow. It does not apply to products that regularly contact the mucous membrane of the eye, are injected, are intended for internal use, or alter appearance for more than 24 hours where removal is not part of customary use. A single eyeliner or eye cream can void it. Adverse-event reporting, labelling, and safety substantiation still apply to every firm, exempt or not. A serious adverse event must be reported to the FDA within 15 business days, with follow-up information within a further 15 business days.

A foreign facility that must register has to designate a US Agent who resides or maintains a place of business in the US and is physically present there. A mailbox or answering service does not qualify. The US Agent is the FDA’s communication liaison for the foreign facility, and this role is separate from being the Responsible Person. Separately, the product label must include a US contact for adverse-event reporting.

Key dates
13 December 2024: the GPSR (Regulation (EU) 2023/988) became fully applicable. It applies to all non-food consumer products, including cosmetics, sold to EU customers regardless of the seller's location or size. A product cannot be placed on the EU market without an EU-based economic operator.
1 July 2024: the FDA-enforced compliance date for MoCRA facility registration and product listing, moved from the statutory 29 December 2023 after a six-month enforcement delay. Products already marketed had to be listed by the deadline; a new product must be listed within 120 days of going on sale in the US.
MoCRA renewals: every two years from each facility's initial registration date. Facilities must renew every two years, and each facility's own renewal date is two years from its initial registration date, so deadlines are staggered through 2026 rather than falling on a single day.
29 December 2024: the date by which US labels had to carry a domestic contact for adverse-event reporting.

The path to compliance

What the process looks like.

The order below holds across the EU, UK, and Switzerland. The US MoCRA path is shorter, since it is registration and listing rather than a full safety dossier and portal notification.

1

Appoint a Responsible Person for each market. Only an entity established in the market can access its portal and be named on the label. For the EU, the UK, and Switzerland, that is a separate appointment each time.

2

Gather the technical data. This is the full formula with INCI names and percentages, the manufacturing details and a good manufacturing practice statement, raw-material specifications and safety data, packaging information, and any test results you already hold.

3

Run the required testing. Stability, challenge or preservative-efficacy testing, microbiological testing, and packaging-compatibility testing feed the safety assessment. Stability testing is usually the longest single step, which is why the whole process runs in months, not weeks. Any claim you want to make (SPF, water resistance, moisturisation, anti-aging) needs its own substantiation study.

4

Have the CPSR written and signed. A qualified safety assessor completes Part A and signs Part B. Without a signed Part B, the PIF is incomplete and the product cannot be placed on the EU, UK, or Swiss market.

5

Assemble the PIF. The safety report, product description, manufacturing method, claim substantiation, and animal-testing data go into one file the Responsible Person holds for ten years.

6

Notify the product. The Responsible Person files the CPNP notification for the EU, or the SCPN notification for Great Britain, before the product is placed on the market. Switzerland has no notification step, but the self-monitoring dossier must be ready for cantonal inspection.

7

Keep the file current. Responsible Person liability continues for as long as the product is sold. Formula changes, new claims, and new variants all update the dossier.

What goes wrong

Common mistakes that cause recalls and takedowns.

Most enforcement problems come from a short list of errors. Market-surveillance findings and first-timer failures cluster around the same causes.

An incomplete or missing PIF. A missing safety report, missing manufacturing details, or a PIF that cannot be produced on request is one of the most common findings, and it can force a product withdrawal.

Using a prohibited or restricted ingredient. An ingredient banned or restricted under the annexes of Regulation 1223/2009 is a frequent cause of recalls and Safety Gate alerts.

Labelling errors. Missing batch numbers, warnings not translated into the required language, and a missing INCI list all trigger relabelling or withdrawal.

Failing to notify. Skipping CPNP or SCPN before placing a product on the market leaves it non-compliant even if everything else is in order.

Unsubstantiated claims. Claims that cannot be backed by evidence are a recurring weakness under the Article 19 labelling rules.

Microbiological contamination. Products that fail microbiological quality, often because challenge testing was skipped, are a standing recall cause.

Making drug claims. In the US, claims such as treating eczema or reducing inflammation reclassify a product as an over-the-counter drug, taking it out of MoCRA and into stricter drug rules. This has drawn FDA warning letters.

Assuming one market covers another. Treating an EU notification as UK cover, or an EU Responsible Person as Swiss cover, leaves a product unlawfully placed in the market it was never notified in.

Selling online

What marketplaces require.

Marketplace rules now mirror the law, and in some cases enforce it faster than the authorities do.

Marketplaces such as Amazon, Etsy, and Notino now ask for proof that a Responsible Person is appointed before they will list cosmetics, which makes the appointment a commercial gatekeeper as well as a legal one. Enforcement is uneven across platforms, and that unevenness catches sellers out.

Etsy does not check for a CPSR at the point of listing, which lulls sellers into thinking they do not need one. They remain fully liable and can be asked for documentation at any time. Amazon EU actively demands the CPSR and PIF and suspends listings that do not have them. Without a valid Responsible Person, Amazon can suppress a listing so shoppers cannot see it, suspend the whole account, lock FBA inventory in the country it sits in, and goods can be seized and destroyed at customs.

GPSR adds a further layer. Since 13 December 2024, a product cannot be placed on the EU market without an EU-based economic operator, and marketplaces enforce this for third-party sellers. In Great Britain, failing to notify OPSS can carry a fine and up to three months' imprisonment, fines are unlimited in England and Wales and up to 5,000 pounds in Scotland and Northern Ireland, and OPSS and Trading Standards can prohibit sales until compliance is achieved.

Common questions

Frequently asked questions.

Plain answers to the questions brands ask most often before they expand.

Yes. Every cosmetic placed on the EU market needs a signed Cosmetic Product Safety Report inside its Product Information File, whether it sells on Shopify, Amazon, Etsy, or a brand’s own site. There is no exemption for online-only or small sellers. Some marketplaces do not check at the point of listing, but the legal requirement still applies and authorities can ask for the report at any time.

Yes. Regulation 1223/2009 has no small-business exemption and no turnover threshold. A one-person operation selling a few bars of soap faces the same Responsible Person, PIF, and CPSR requirements as a large brand.

No. CPNP and SCPN are separate systems that do not share data. A CPNP notification covers the EU only. To sell in Great Britain you need a separate SCPN notification through OPSS and a UK-established Responsible Person.

Yes. A brand selling into both markets needs a UK-established Responsible Person for Great Britain and a separately established EU Responsible Person for the EU. One appointment cannot cover both. Each Responsible Person’s name and address goes on the label for its own market.

Under the Windsor Framework, the Northern Ireland market follows EU Regulation 1223/2009, so it aligns with the EU Responsible Person and CPNP route rather than the Great Britain UK Responsible Person and SCPN route.

No. The responsible person for Switzerland must have an address on Swiss territory, and the obligation cannot be delegated to anyone abroad. If no Swiss responsible person is appointed, the company’s CEO or equivalent legal representative becomes the responsible person by default.

No. Switzerland has no pre-market notification and no access to CPNP. Control relies on cantonal laboratories carrying out post-market inspections, so a brand must keep a self-monitoring dossier ready to show on request.

An existing PIF compiled abroad can satisfy Swiss requirements if it complies with Swiss cosmetics and labelling rules. It may be written in an official Swiss language or in English. Labelling warnings and instructions must appear in at least one official Swiss language: German, French, or Italian.

A business with average gross annual US cosmetic sales under 1,000,000 US dollars over the previous three years is a small business and is exempt from good manufacturing practice, facility registration, and product listing. The exemption does not apply to products that contact the mucous membrane of the eye, are injected, are for internal use, or alter appearance for more than 24 hours. A single eye product can void it, and adverse-event reporting, labelling, and safety substantiation still apply to everyone.

No. There is no FDA fee to register a facility or list a product under section 607 of the FD&C Act. Registration and listing use FDA’s free Cosmetics Direct tool, which produces submissions in the SPL XML format. An FDA Establishment Identifier is required before submitting.

Facilities renew every two years, with each facility’s own renewal date set two years from its initial registration date. Check the anniversary of your own registration in FDA’s Cosmetics Direct rather than assuming a single shared date.

Yes to both. A foreign facility that must register under MoCRA has to designate a US Agent who resides or has a place of business in the US and is physically present there. A mailbox or answering service does not qualify. The US Agent is the FDA’s communication liaison for the facility, which is a separate role from being the Responsible Person who does the product listing.

No. The FDA does not approve cosmetic products before they go on the market. Listing records the product with the FDA; it is not an approval.

Yes. A new Responsible Person can take over existing CPNP and SCPN accounts and manage future updates, so you are not locked in to your first provider. The transfer is handled so that coverage continues while the change is made.

Plan in months rather than weeks. Stability testing alone can take several months, and it feeds the safety assessment, so a new formulation is the long pole. Once documentation is ready, a CPNP notification is usually quick, but only the appointed Responsible Person can file it. Starting several weeks before the intended launch date is sensible.

The product is placed on the market unlawfully. Authorities can require withdrawal, marketplaces can suppress or remove the listing and lock inventory, and goods can be stopped at customs. Under GPSR, since 13 December 2024 a product cannot be placed on the EU market at all without an EU-based economic operator.

Ready to sell in more markets?

Tell us your products and the markets you are entering. You will receive a fixed quote and a clear path to compliance.

In practice

Compliance, in the real world.

Open regulatory guide beside a cosmetic product
A founder reading a market-entry guideFour-market comparison notes on a desk